$TG

GOTTWALD JOHN D sold $35K of TG (indirect holdings)

GOTTWALD JOHN D sold 4,318 indirectly-held shares of TREDEGAR CORP (TG) at $8.12 on 2026-08-19.

Original reporting
SEC EDGAR · GOTTWALD JOHN D
Published Aug 21, 2026, 4:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 4:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TG
Neutral
high confidence
Mentioned
$TG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TGNeutralLow
01

Why it matters

The disclosed sale is minor and unlikely to affect TG's stock price in the short term.

02

Market read

Routine insider sale with limited market impact.

03

What to watch

The insider still retains 361,921 shares, indicating continued confidence.

Relevance 3/10Novelty 4/10Timing: filing date 2026-08-21

Background

Form 4 filings disclose insider transactions and are required by the SEC. They are primary sources of new information.

Company-level read

Ticker impact

$TGNeutralHigh confidence
Context

John D. Gottwald sold 4,318 shares of Tredegar Corp (TG) for $35,053.52 in a Form 4 filing.

Expected impact

No material move expected.

Evidence & confidence

The transaction size ($35k) is trivial relative to market cap and does not signal a change in insider confidence.

Market effects

None; the sale is company‑specific and does not affect the broader sector.

None; limited to Tredegar Corp shareholders.

None; the filing is a routine insider transaction.

Counterpoint

Even small insider sales can precede larger moves if the insider holds significant knowledge.

Key entities

  • John D. Gottwald

    10% owner of Tredegar Corp who sold 4,318 shares.

  • Tredegar Corp

    Biopharmaceutical company listed on NASDAQ under ticker TG.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TGMed

Tredegar Soars on Q2 Financials

Tredegar Corp (NYSE:TG) reported Q2 2026 results for the period ended June 30, 2026. Net income from continuing operations rose to $6.0 million, or $0.17 per diluted share, from $1.8 million, or $0.05 per share, in Q2 2025. Excluding special items, net income was $6.4 million, or $0.18 per share. Aluminum Extrusions EBITDA was $14.5 million versus $9.3 million in Q2 2025.

$TGMed

TREDEGAR CORP (TG): Results of Operations and Financial Condition

TREDEGAR CORP (TG) filed an SEC Form 8-K — Results of Operations and Financial Condition. TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS • Increased second quarter 2026 results, with net income from continuing operations of $6.0 million, or $0.17 per diluted share, for the second quarter of 2026 compared to $1.8 million, or $0.05 per diluted share, for the second quarte

$DELLLow

Silver Lake Partners V DE (AIV), L.P. (Durban Egon) sold $14.9M of DELL (indirect holdings)

Silver Lake Partners V DE (AIV), L.P. sold 26,990 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $552.79 ($542.78–$564.46, $14.92M total) across 22 trades on 2026-09-15. Filed jointly with Silver Lake Technology Associates V, L.P. (Director), SLTA V (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).